"What has been missing is the patient's perspective," says one industry consultant. The future of clinical pathways is patient-centric: an approach that balances the long-standing focus on ...
Linda Bosserman, M.D., joined City of Hope in Los Angeles nine years ago as a medical oncologist specializing in breast cancer and value-based care. During her 26 years in private practice, prior to ...
Expanding the Multidisciplinary Team in Prediagnostic Care of Lung Cancer: How Else Can We Improve Time to Targeted Treatment in Metastatic Non–Small-Cell Lung Cancer? In the article that accompanies ...
Clinical evidence is always evolving, but traditional clinical process map development and EHR build cycles often take months. In his upcoming HIMSS26 session, one informatics leader will show how to ...
An administrator in the Geisinger Cancer Institute discusses the rollout of ClinicalPath. Clinical pathways in cancer care are beyond the “new” phase, but oncology practices and health systems are ...
Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management. The panel discussion revolved around the ...
FGFR2 fusion detection in plasma: A new era in the clinical monitoring of iCCA. Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) plus best supportive care (BSC) versus placebo ...
In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, ...
New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback